Skip to main content
DCM
NYSE Trade & Services

Shareholders Approve 25M Preferred and 25M Class B Common Authorizations

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Consumer
Sentiment info
Negative
Importance info
7
Price
$3.36
Mkt Cap
$10.024M
52W Low
$2.815
52W High
$7.82
52W Position info
19% above low
Off High info
57% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

DCM sits 19% above its 52-week low of $2.815.

Summary

DeFi Capital Markets shareholders approved charter amendments authorizing 25 million preferred shares and 25 million class B common shares, plus additional shares underlying its October 2026 convertible notes. No shares were issued — these are authorizations the board can use later.


Key Events · Corporate Governance and Compliance · DCM

  • Two New Share Classes Authorized

    Stockholders approved amendments authorizing 25,000,000 preferred shares and 25,000,000 class B common shares, with preferred rights and preferences to be set by the board from time to time. No shares were issued.

  • Convertible Note Share Issuance Cleared

    Proposal Five approved, for NYSE American Rule 713(a) purposes, the issuance of additional common shares underlying convertible notes under the amended and restated securities purchase agreement dated October 9, 2026.

  • Dilution Headroom Is Large

    The 25,000,000 preferred and 25,000,000 class B common authorizations compare with 3,028,463 shares outstanding as of the October 20, 2026 record date — authorization only, but substantial future dilution capacity.

  • Directors Elected, Auditor Ratified

    Milton C. Ault, III received 1,657,780 votes for and Ronald A. Seff, M.D. received 1,579,967 votes for, each elected to a three-year Class I term. CBIZ CPAs P.C. was ratified as auditor for fiscal 2026 with 2,124,421 votes for.


Analysis · DCM · Trade & Services

Shareholders handed the board permission to create two large new share classes — 25,000,000 preferred and 25,000,000 class B common — with terms left entirely to the board's discretion. No shares have been issued; this is authorization only. Against 3,028,463 shares currently outstanding, that is enormous potential dilution if the board ever uses it, and the blank-check preferred is the more consequential piece because its rights and preferences can be set without another vote. Separately, approval of additional shares underlying the October 9, 2026 convertible notes clears the NYSE American Rule 713(a) hurdle, meaning the noteholders' conversion shares can now be issued.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, DCM was trading at $3.36 on NYSE in the Trade & Services sector, with a market capitalization of approximately $10M. The 52-week trading range was $2.82 to $7.82. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

DCM - Latest Insights